| Code | 0813C | ||||||||||
| MA number | 59/0368/16-S | ||||||||||
| Product Form: | sol inf 1x25 ml/2,5 g (liek.inj.skl.) | ||||||||||
| MA Status: | D - Marketing Authorisation valid for an unlimited period | ||||||||||
| Type of procedure: | Decentralised | ||||||||||
| MAH, country: | Octapharma (IP) SPRL, Belgium | ||||||||||
| Therapeutic Class: | 59 - IMMUNOPRAEPARATA | ||||||||||
| ATC: |
|
||||||||||
| Shelf life: | 36 | ||||||||||
| Route of admin.: | Intravenous use |
| Prescription Status: | Medicinal product subject to restricted medical prescription. |
| Legal basis: | Article 8(3) application - known active substance |
| MA issued: | 17.08.2016 |
| Pediatric posology: | Yes |
| Pediatric warnings: | Yes |
| SPC: |
SPC_Panzyga_06.2025.pdf
|
| PIL: |
PIL_Panzyga_06.2025.pdf
|
| Safety feature | Yes |
| Data update: | 14.01.2021 |
